Jerry R. Colca PhD
Biochemistry and Molecular Genetics
Kalamazoo, Michigan, United States of America
Connect with the speaker?
Dr. Colca has been involved in diabetes and related metabolic disease research and drug development for his entire career. His postgraduate training in physiology and biochemistry was at the University of Houston and Washington University. He joined the Upjohn Company in 1984 and worked on the team that selected pioglitazone for development.
He became a leader of the Diabetes Project Team that took pioglitazone and other experimental drugs into clinical development. During this time he also led a large laboratory that had expertise in evaluating anti-diabetic therapeutics for efficacy, pharmacokinetics, and bioavailability. Dr. Colca co-founded MSDC with Dr. Rolf Kletzien in 2006 and is currently the President and CSO of MSDC.
He became a leader of the Diabetes Project Team that took pioglitazone and other experimental drugs into clinical development. During this time he also led a large laboratory that had expertise in evaluating anti-diabetic therapeutics for efficacy, pharmacokinetics, and bioavailability. Dr. Colca co-founded MSDC with Dr. Rolf Kletzien in 2006 and is currently the President and CSO of MSDC.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)
4th Annual Non-alcoholic Steatohepatitis (NASH) Summit
In-Person Event
Gastroenterology ...
Dec 15 - 18, 2020
Boston, Massachusetts, USA
Global NASH Congress 2020
- In-Person Event
- Hepatology ...
- Feb 10 - 11, 2020
- London, England, GB
2nd Annual NASH Summit 2018
- In-Person Event
- Gastroenterology
- Apr 23 - 25, 2018
- Boston, Massachusetts, USA
Global NASH Congress 2018
- In-Person Event
- Gastroenterology ...
- Feb 26 - 27, 2018
- London, England, GB
The Biology of Aging: Novel Drug Targets for Neurodegenerative Disease
- In-Person Event
- Neurology ...
- May 09, 2014
- New York, New York, USA
Quick Links
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com